MedPath
NMPA Approval

Ranitidine Hydrochloride Capsules

国药准字H51021590

January 15, 2020

Drug Information

盐酸雷尼替丁胶囊

胶囊剂

0.15g(按C13H22N4O3S计)

化学药品

January 15, 2020

Company Information

Applicant Company

Manufacturing Company

四川省成都市海峡两岸科技产业开发园

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸雷尼替丁胶囊 - NMPA 批准文号 | MedPath